⌘K

Login Start Free

Home/Filings/4/0001104659-25-118985

4//SEC Filing

Henderson Jane 4

Accession 0001104659-25-118985

CIK 0001974640other

View on SEC.gov Company Profile

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 8:02 PM ET

Size

5.0 KB

Accession

0001104659-25-118985

Insider Transaction Report

Form 4

Period: 2025-12-04

Apogee Therapeutics, Inc.APGE

Chief Financial Officer

Transactions

Sale
Common Stock
2025-12-04$75.00/sh−1,500$112,500→ 194,871 total

Footnotes (1)

[F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 27, 2024.

Documents

1 file

4
tm2532835-2_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Apogee Therapeutics, Inc.

CIK 0001974640

Entity typeother

Related Parties

1

filerCIK 0001422304

Filing Metadata

Form type: 4
Filed: Dec 4, 7:00 PM ET
Accepted: Dec 5, 8:02 PM ET
Size: 5.0 KB

View on SEC.gov